MultiCell Technologies Inc (MCET)

[simon wagstaff]

I didn't say that the patents were not of value, I said that their immediate value was undetermined. I most heartily agree that IP is basically all MCET has of value at this time. Unfortunately the value of the IP right now is to mainly fuel speculative pumps and dumps.

It is unfortunate that MCET gave away the rights of their liver cells for ADME/TOX to Corning who seems to be doing nothing with them. That is a good market and the reason that I invested in MCET in the first place.

100 million shares at a penny a share just about covers their losses for last year. I think MCET has potential but unfortunately a lot of it is mis-represented specifically on the Yahoo board.

And Mr.

"I have 38 years of health science experience avoiding the people that claim they know everything; the same people that are killing millions of patients every year. "

Millions? Really? And MCET will save them?

I clearly know nothing. Please tell me;

1) the drug or product MCET has closest to market and the expected revenue?
2) Which of the patents either held by MCET or licensed by them has the most value?
3) What are the specific target diseases of MCET's programs?

Or, is simply "meeting unmet medical needs" enough to make a company billions?

Let's also keep in mind that big pharma, like Astra Zeneca for example is shedding a lot of research groups and selling divisions, like animal health. They may be looking for new ways to enrich their drug portfolios but they are not as flush with cash as you might think and they are not throwing big ole bags o cash at any company with a few patents and a live body to answer the phone.

I hope this post replaces my other one as the "the funnist thing ihave herd."

Good luck with the big run up next week! Going to a buck a share for sure!